Status:

NOT_YET_RECRUITING

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Lead Sponsor:

Applied Biology, Inc.

Collaborating Sponsors:

Follea International Limited

Daniel Alain, Inc.

Conditions:

Androgenetic Alopecia

Female Pattern Baldness

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The primary objective of the study is to assess the safety and efficacy of DA-005 and DA-002 as a treatment for hair loss (androgenetic alopecia).

Detailed Description

DA-005 is a botanical supplement with demonstrated HIF-1a inhibitory action. The ingredients were tested in-vitro and have demonstrated the HIF-1a inhibitory effect. The primary aim of the study is to...

Eligibility Criteria

Inclusion

  • Age 18 or older
  • Diagnosed with androgenetic alopecia
  • Willing and able to apply the treatment as directed, comply with study
  • Otherwise healthy
  • Able to give informed consent

Exclusion

  • A medical history that may interfere with study objectives
  • Women who are pregnant, lactating, or planning to become pregnant during the study period
  • Subjects who have experienced a clinically important medical event within 90 days of the visit (e.g., stroke, myocardial infarction, etc)
  • Subjects who have known allergies to any excipient in DA-002 or DA-005
  • Subjects who are currently participating in another clinical study or have completed another clinical study with an investigational drug or device in the treatment area within 30 days prior to study treatment initiation
  • Subjects who have used any topical prescription medications in the treatment area within 30 days prior to study treatment initiation
  • Subjects who have had a dermatological procedure such as surgery in the treatment area within 30 days prior to study treatment initiation
  • Subject is unable to provide consent or make the allotted clinical visits

Key Trial Info

Start Date :

January 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 12 2025

Estimated Enrollment :

516 Patients enrolled

Trial Details

Trial ID

NCT06501924

Start Date

January 15 2025

End Date

December 12 2025

Last Update

December 19 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss | DecenTrialz